Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This indicates a minor update to the study page metadata without changing its content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedFooter now includes references to the Moffitt Clinical Trials website and sponsor organization, plus a 'Helpful Links Provided by' attribution. The revision tag has been updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a newer page build without changes to the study content or data.SummaryDifference0.1%

- Check54 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to assist users. The Intervention/Treatment header was reformatted to 'Intervention / Treatment' and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check61 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This typically reflects minor updates or fixes applied to the page content or documentation.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page footer no longer shows branding lines for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with the 'Helpful Links Provided by' label. This changes how the sponsoring institution is presented and credited on the page.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.